Loreclezole
Loreclezole is a pharmaceutical drug that belongs to the class of anticonvulsants. It is primarily used in the treatment of epilepsy and other seizure disorders. Loreclezole functions by modulating the activity of gamma-aminobutyric acid (GABA), a key inhibitory neurotransmitter in the central nervous system.
Mechanism of Action[edit]
Loreclezole enhances the effects of GABA by binding to the GABA_A receptor and increasing the duration of chloride ion channel opening. This action results in hyperpolarization of the neuronal membrane, making it less likely to fire and thereby reducing the likelihood of a seizure.
Pharmacokinetics[edit]
Loreclezole is well-absorbed after oral administration and has a bioavailability of approximately 80%. It is metabolized in the liver primarily by the cytochrome P450 enzyme system and is excreted mainly via the kidneys. The half-life of loreclezole is approximately 12 hours, allowing for twice-daily dosing.
Indications[edit]
Loreclezole is indicated for the management of various types of epilepsy, including:
Side Effects[edit]
Common side effects of loreclezole include:
Serious side effects may include:
Contraindications[edit]
Loreclezole is contraindicated in patients with:
- Known hypersensitivity to loreclezole or any of its components
- Severe liver disease
- Severe renal impairment
Drug Interactions[edit]
Loreclezole may interact with other medications, including:
Monitoring[edit]
Patients on loreclezole should be regularly monitored for liver function, renal function, and complete blood counts to detect any potential adverse effects early.
See Also[edit]
References[edit]
External Links[edit]
-
 | This medical article is a stub. You can help WikiMD by expanding the page. |
